The effect of Ginseng augmentation on the intensity of opioid withdrawal symptoms
Phase 2
- Conditions
- opioid withdrawal.Mental and behavioural disorders due to use of opioids / Dependence syndrome
- Registration Number
- IRCT201009063106N4
- Lead Sponsor
- Pharmaceutical sciences branch of Islamic Azad university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 36
Inclusion Criteria
Iinclusion criteria: -all patients were male abusing opioids for at least 1 year -age range was between 18 and 50. -all patients were at the beginning of induction phase of MMT protocol -subjects should not recieve any other medication which affects withdrawal symptoms. Exclusion criteria: -incidence of any allergic effect to ginseng or other ingredients of capsules -patient unlikely to continue the intervention -positive urine tests indicating abuse of any opioid or stimulant drug -missing more than 1 dose of ginseng or a day of methadone treatment
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical opioid withdrawal symptoms. Timepoint: days 0,1,7,10,15. Method of measurement: clinical opioid withdrawal scale.
- Secondary Outcome Measures
Name Time Method Methadone dosage. Timepoint: every day. Method of measurement: base on ducuments and patients records.